Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR1 | P21453 | 3/20 | 0.58 |
| ▸ | EGFR | P00533 | 9/20 | 0.56 |
| ▸ | ERBB3 | P21860 | 8/20 | 0.56 |
| ▸ | KMO | O15229 | 2/20 | 0.54 |
| ▸ | KDR | P35968 | 1/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | JAK2 | O60674 | 1/20 | 0.50 |
| ▸ | TYK2 | P29597 | 1/20 | 0.50 |
| ▸ | CNR1 | P21554 | 1/20 | 0.49 |
| ▸ | TNNI3K | Q59H18 | 1/20 | 0.48 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | NPY1R | P25929 | 1/20 | 0.46 |
| ▸ | NPY2R | P49146 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3221150 | 1.00 | S1PR1 (0.58) | S1PR1EGFRERBB3KMOKDR | |
| SCHEMBL3226154 | 0.93 | S1PR1 (0.61) | S1PR1EGFRERBB3KMOKDR | |
| SCHEMBL3229139 | 0.89 | S1PR1 (0.72) | S1PR1EGFRERBB3KMOKMT2A | |
| SCHEMBL3228067 | 0.88 | EGFR (0.58) | S1PR1EGFRERBB3KMOKMT2A | |
| SCHEMBL3222525 | 0.88 | EGFR (0.73) | S1PR1EGFRERBB3KMOKMT2A | |
| SCHEMBL3227236 | 0.85 | S1PR1 (0.57) | S1PR1EGFRERBB3KMOKDR | |
| SCHEMBL3229082 | 0.85 | KCNH2 (0.59) | S1PR1EGFRERBB3KMOTNNI3K | |
| SCHEMBL3222813 | 0.82 | EGFR (0.64) | S1PR1EGFRERBB3KMOKMT2A | |
| SCHEMBL3219928 | 0.82 | NPC1 (0.56) | S1PR1EGFRERBB3KMOKMT2A | |
| SCHEMBL3225334 | 0.82 | RAB9A (0.57) | S1PR1KMT2AMEN1JAK2TYK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010020432-A8 | COMPOUNDS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | BIOMARIN IGA LIMITED (BS) | 2010-03-11 | — | — | WO | claimed |
| WO-2010020432-A2 | COMPOUNDS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | SUMMIT CORPORATION PLC (GB) | 2010-02-25 | — | — | WO | claimed |
| WO-2010020432-A8 | COMPOUNDS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | BIOMARIN IGA LIMITED (BS) | 2010-03-11 | — | — | WO | disclosed |
| WO-2010020432-A2 | COMPOUNDS FOR TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY | SUMMIT CORPORATION PLC (GB) | 2010-02-25 | — | — | WO | disclosed |